abemaciclib,anastrozole,letrozole
eli lilly,novartis
['breast', 'abemaciclib', 'bcsm', 'monarch 3', 'abema']
abemaciclib prolonged overall survival when added to a nonsteroidal aromatase inhibitor in hormone receptor positive, her2 negative breast cancer, according to updated findings from the monarch 3 trial. #bcsm #esmo22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.